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Porcine reproductive and respiratory syndrome virus (PRRSV) is a major pathogen of swine worldwide and causes considerable
economic loss. Identifying speciﬁc cell signaling or activation pathways that associate with variation in PRRSV replication and
macrophage function may lead to identiﬁcation of novel gene targets for the control of PRRSV infection. Serial Analysis of
Gene Expression (SAGE) was used to create and survey the transcriptome of in vitro mock-infected and PRRSV strain VR-2332-
infected porcine alveolar macrophages (PAM) at 0, 6, 12, 16, and 24 hours after infection. The transcriptome data indicated
changes in transcript abundance occurring in PRRSV-infected PAMs over time after infection with more than 590 unique tags
with signiﬁcantly altered transcript abundance levels identiﬁed (P<. 01). Strikingly, innate immune genes (whose transcript
abundances are typically altered in response to other pathogens or insults including IL-8, CCL4, and IL-1β) showed no or very
little change at any time point following infection.
1.Introduction
Porcine Reproductive and Respiratory Syndrome Virus
(PRRSV), the causative agent of porcine reproductive and
respiratory syndrome (PRRS) in swine, is a member of the
Arteriviridae family in the order Nidovirales. PRRSV causes
signiﬁcant losses to the swine industry worldwide [1]a s
a result of both reproductive failure (late-term abortions
and stillbirths) in pregnant sows and respiratory disease
(pneumonia) in nursery and grower/ﬁnishing pigs [2].
Infection with PRRSV also predisposes pigs to infection by
bacterial pathogens as well as other viral pathogens [3–7].
Clinical disease caused by PRRSV is highly variable, ranging
from mild, subclinical infections to acute deaths of swine of
any age [8]. Diﬀerences in virulence have been attributed
to numerous factors including host genetics, management
practices, and virus strain heterogeneity [9–16].
RelativelylittleisknownabouttheinteractionsofPRRSV
and host cells. The primary cellular target of PRRSV is the
porcine alveolar macrophage (PAM) [17, 18]. PRRSV has
been shown to replicate to varying degrees in peritoneal
macrophages, pulmonary intravascular macrophages, type
II pneumocytes, testicular germ cells, and PAMs [19–22].
MARC-145 cells, a monkey kidney cell line, are used to
propagate this fastidious virus in culture. A putative cell
surface receptor has been identiﬁed that may contribute to
the propensity of PRRSV to readily infect these cells. The
CD163 protein, sialoadhesin, and heparan sulphate have
been reported to play signiﬁcant role in helping PRRSV
attach and be internalized into cells [23].2 Advances in Virology
A primary function of the PAM is to combat bacterial
insults within terminal airways of the lung, in part, by
regulating the local host immune response in the alveoli.
Reports have shown pigs infected with PRRSV have a
higher rate of concurrent or secondary bacterial infections
[23, 24]. This has led investigators to examine the eﬀect
of PRRSV infection on bacterial killing by PAMs [25–
28]. Studies have reported PRRSV infection signiﬁcantly
decreases production of superoxide anion and hypohalous
acid, both of which contribute to the oxidative ability of
PAMstokillbacteria[25].Anotherreport[29]demonstrated
that PRRSV infection resulted in cytotoxicity to PAMs that
led to a 40% reduction in phagocytic uptake of Escherichia
coli. The speciﬁc mechanism(s) by which PRRSV infection
alters PAM function is unknown. It has been reported
PRRSV infection of PAMs results in lowered transcript
abundanceofproinﬂammatoryresponsecytokinesincluding
TNF-α,I L - 1 α,a n dM I P - 1 β [30]. However, other studies
showed that TNF-α,I L - 8 ,I F N - α,a n dI L - 1 β transcripts are
not signiﬁcantly altered by PRRSV infection [31–35]. Thus,
it remains unclear which macrophage genes PRRSV aﬀects
upon infection.
One study attempting to better understand the altered
transcript abundance of PAMs upon infection by PRRSV
used diﬀerential display reverse-transcription PCR to iden-
tify host cell gene responses to PRRSV infection of PAMs
over a 24 hour period [35]. Four transcripts were identiﬁed
that speciﬁcally responded to PRRSV infection and were
induced in vivo in tissues where PRRSV persistently resides.
Of the four transcripts identiﬁed, three of these came
from identiﬁed genes and the fourth remains a novel
expressed sequence tag (EST). The three genes identiﬁed
are Mx1 (myxovirus resistance), UBP (ubiquitin protease),
and RHIV-1 (RNA helicase). Presumably there are more, yet
to be identiﬁed, genes that diﬀerentially respond to PRRSV
infection.
Various research techniques provide the potential to
look at cellular processes and response to infection in a
comprehensive and unbiased manner [36]. Combined with
targeted approaches such as gene knockouts, transgenics,
targetedoverexpressionandothermethods,itisnowpossible
todissectpathwaysandnetworksofgenes,proteinsandsmall
molecules that deﬁne cellular functions. Technologies have
been developed that permit high throughput quantiﬁcation
oftranscriptabundance.Mostprominentofthesearevarious
forms of solid phase microarray hybridization [37]a n ds e ri a l
analysis of gene expression (SAGE; [38, 39]). Information
derived from these methods can be exploited in a number
of ways including development of diagnostic assays, under-
standing molecular mechanism(s) behind disease states and
formulating intervention regimens to inhibit or minimize
infections and negative outcomes. SAGE has been used
extensively to evaluate changes in transcript abundance
in a number of experimental systems. The availability of
nearly 600,000 swine and over 1 million bovine ESTs in the
NCBI dbEST greatly increases the utility of SAGE for gene
expression studies in these species. SAGE has also been used
for gene discovery and enabled identiﬁcation of genes not
previously known to be expressed in granulocytes [40], and
Table 1: Summary statistics of SAGE libraries.
Library
(hours PI)
Noninfected Infected
0 6 12 16 24
Tags sequenced 111,214 96,968 103,662 134,990 196,421
Unique tags 24,367 30,709 33,601 33,255 37,942
PRRSV tag
(CGGCCGAAAT)
0 255 9500 6902 3632
in identifying potential new cell surface diagnostic markers
in astrocytomas [41].
It is our hypothesis that PRRSV infection of PAMs alters
their normal transcriptome in a manner that enables
virus replication and dysregulates the normal host immune
response. Here we report a comprehensive evaluation of
transcript abundance levels in noninfected and PRRSV-
infected PAMs as an initial step towards a more compre-
hensive understanding of PRRSV pathogenesis. Although a
comprehensive understanding of diﬀerential posttranscrip-
tionalandposttranslationalresponsesinPAMsremainstobe
determined, detection of altered transcriptome patterns may
identify PRRSV virulence mechanisms that contribute to a
delayed or lack of a protective immune response and viral
persistence.
2. Results
2.1. Serial Analysis of Gene Expression. Total cellular RNA
was prepared from in vitro PRRSV-infected PAMs at 0, 6, 12,
16 and 24 hours after infection, and mock-infected PAMs
at 0 and 24 hours. Five SAGE libraries were constructed
from the 0 hour mock-infected and the 6, 12, 16 and 24
hours PRRSV-infected cells. The libraries were subsequently
sequenced to obtain approximately 100,000 tags each, with
the exception of the 24 hour infected library, which was
sequenced to nearly 200,000 tags (Table 1). Five SAGE
libraries yielded 643,255 sequenced tags that were used to
populate a modiﬁed Identitag database. Examination of
the SAGE data indicated that there were major changes
in transcript abundance occurring in the PRRSV-infected
PAMs based on more than 590 unique tags with signiﬁcantly
altered transcript abundance (P<. 001 with Bonferroni
correction). Table 1 summarizesthegeneralstatisticsofthese
libraries. Tags with a frequency of 1 were not considered for
quantitative purposes, because they could represent artifacts
of sequencing or of the SAGE procedure [42].
2.2. Functional Classiﬁcation of Transcripts with Changes in
Abundance. To obtain a greater understanding of cellular
responses to PRRSV, the identiﬁed transcripts were further
categorized with biological processes, deﬁned by the Gene
Ontology Consortium (http://www.geneontology.org/),
according to the Ingenuity Pathway Analysis (IPA) database
(Ingenuity Systems, http://www.ingenuity.com/). Fischer’s
e x a c tt e s tw a su s e dt oc a l c u l a t eaP-value determining
the probability that each biological function assigned
to that data set is due to chance alone. TranscriptionalAdvances in Virology 3
abundance diﬀerences between high-level function groups
observed during the ﬁrst 24 hours of PRRSV infection were
compared. Cellular movement, which describes the cellular
functions associated with movement and localization of
cells, was signiﬁcantly upregulated among differentially
expressed transcripts in the ﬁrst 6hp.i. Cell-to-cell signalling
and interaction, which describes functions involved in inter-
cellular interactions and includes functions associated with
speciﬁc cellular components that are involved in signalling
and interaction, an important aspect of macrophage
function, included the most signiﬁcantly down-regulated,
diﬀerentially expressed transcripts. Our interest was in those
expression changes that aﬀect PAM function; particularly in
regard to innate immunity, antigen presentation, and intra-
and extra-cellular signalling.
2.3. Detection of Viral RNA Transcripts. Analysis of the data
revealed the presence of the tags derived from transcripts
produced by the infecting PRRSV strain; thus conﬁrming
the virus infected the PAMs as intended. PRRSV produces
3  co-terminal subgenomic RNAs, thus all viral RNAs had
the same tag [43]. The viral tag, not detected in the mock-
infected library, was ﬁrst present at 6-hours PI and increased
in number to its highest point at 12 hours after which it
declined (Table 1). These data were validated by real-time
PCR (data not shown). There was a high level of viral RNAs
present in the infected cells at 12 hours after infection, where
viral RNAs accounted for almost 10% of all polyadenylated
RNAinthesecells.TheamountofviralRNAdeclinedby24h
hours after infection perhaps because of a decline in RNA
replication/transcription, degradation of viral RNAs, release
of virus from the cells or a combination of all three.
2.4. Real-Time PCR Validation of Transcript Abundance
Levels. Changes in transcript abundance of genes of interest
were validated using real-time reverse transcriptase (RT)-
PCR (Figure 1). In this study, β2-microglobulin was found
to have stable transcript levels across all times tested
(Figure 1(a)) and was chosen as the internal control in all
real-time RT-PCR assays.
Real-time RT-PCR ampliﬁcation of cellular transcripts
previously shown to have altered transcript abundance
levels following PRRSV infection was done to conﬁrm
the infection had proceeded as expected (Figure 1(b)). As
expected, transcripts encoding the proteins Mx1 and rHIV
(a RNA helicase) showed 6.4- and 4.8-fold increases at
24 hours PI, respectively (Figure 1(b)), and were induced
between 0 and 12h postPRRSV-infection [35]. The tran-
scripts encoding the proinﬂammatory proteins IL-1α and
CCL4(macrophageinﬂammatoryprotein,MIP-1β)declined
in abundance as previously demonstrated [44]. The tags
for the Mx1 transcript were identiﬁed in the 16 and 24
hour infected SAGE libraries but at very low levels and were
therefore insigniﬁcant following normalization of the SAGE
data.
Overall, the real-time RT-PCR validation described
above, in addition to that which was not shown, had a
high degree of correlation to the SAGE data, thus providing
conﬁdence that the tag counts for each library was an accu-
rate representation of transcript abundance levels in these
PAMs. This demonstrated that additional validation of the
SAGE libraries by real-time PCR was not necessary.
2.5. Transcripts Encoding Immune Response Proteins. There
was a general decline in numbers of the cytokine and
chemokine transcripts, indicating that there was no induc-
tion of expression that would be expected in an innate
immune response to a viral infection. SAGE revealed
decreased transcript abundance IL-1α and IL-1β (Tables
2(a) and 2(b)). RANTES, MIF, MCP3 and CXCL5, showed
increased transcription during the infection (Table 2(a)).
MCP3andCXCL5showedincreasesonlylateintheinfection
process, while CXCL8 (IL-8) showed increased transcription
early in the infection then decayed to noninfected levels
(Table 2(a)). Interestingly, there were 2 tags identiﬁed for
CXCL8 with both showing similar patterns of expres-
sion. Proinﬂammatory cytokines CXCL8 and CXCL5 are
chemoattractants for neutophils, IL-1α and IL-1β are impor-
tant proinﬂammatory cytokines and would be expected to
be increased early in infection. IL-1α and IL-1β promote
inﬁltration of various leukocytes by inducing chemokine
production and increasing expression of various adhesion
molecules on mesenchymal cells and postcapillary venule
endothelial cells.
The increase in transcript numbers of cytochrome p450
3A29,BNIP3(aproapoptoticprotein),andGRP78(anendo-
plasmic reticulum chaperone protein) were also conﬁrmed
(Figure 1(c)). Changes in levels of transcripts encoding
proteinsinvolvedindefenseandtheinnateimmuneresponse
were also validated (Figure 1(c), Table 2). Changes in levels
of transcripts encoding CCL3 (MIP1-α), CXCL8 (swine IL-
8), and IL-1β were found to be very close to that indicated
by SAGE with all declining as the infection progressed. An
additional transcript of interest, that encoding IL-6, was not
found represented in the SAGE database. Interestingly, the
transcript encoding IL-6 does not encode a tag (no Nla
III restriction site in the transcript), therefore, it was not
detected by SAGE. The only information on IL-6 transcript
abundance levels in these cells was obtained by real-time
RT-PCR. This revealed a sharp decline in IL-6 transcripts
during the ﬁrst 24 hours following infection by PRRSV
(Figure 1(c)).
2.6. Additional Pathways and Functions. Data was evaluated
for indications of activation of intracellular signaling or
other pathways in PRRSV-infected PAMs. Tags derived from
transcripts encoding major proteins making up the AP-
1 immediate-early transcriptional complex were identiﬁed
(Table 2(c)). Tags corresponding to the c-jun, junB, junD
and c-fos transcripts showed decreased abundance levels,
dropping to the lowest levels at 12 hours and showing some
rebound by 24 hours PI. These data indicated that there was
no overt induction of the AP-1 signaling pathway following
PRRSV-infection. Similarly, activation of NF-κBw a sn o t
observed (Table 2(c)). A20, a negative regulator of NF-κBa s
well as a gene that is transcriptionally activated by NF-κB,4 Advances in Virology
0
0.5
1
R
e
a
l
-
t
i
m
e
R
T
-
P
C
R
t
r
a
n
s
c
r
i
p
t
a
b
u
n
d
a
n
c
e
(
f
o
l
d
c
h
a
n
g
e
)
1.5
2
RT-PCR
24 mock
R
e
a
l
-
t
i
m
e
R
T
-
P
C
R
t
r
a
n
s
c
r
i
p
t
a
b
u
n
d
a
n
c
e
(
f
o
l
d
c
h
a
n
g
e
)
R
e
a
l
-
t
i
m
e
R
T
-
P
C
R
t
r
a
n
s
c
r
i
p
t
a
b
u
n
d
a
n
c
e
(
f
o
l
d
c
h
a
n
g
e
)
06 1 2
(a)
(b)
β2-microglobulin
16 24
Time post-infection (hours)
Time post-infection (hours)
Time post-infection (hours)
Time post-infection (hours)
Time post-infection (hours)
0
0
10
20
30
40
0
10
20
30
40
0
2
4
6
8
0 6 12 16 24 0 6 12 16 24
2
4
6
8
10
12
Mx1
CCL4 IL-1α
RHIV
SAGE
RT-PCR
24 mock
SAGE
RT-PCR
24 mock
0 6 12 16 24 0 6 12 16 24
SAGE
RT-PCR
24 mock
SAGE
RT-PCR
24 mock
0
0.2
0.4
0.6
0.8
1
1.2
1.4
0
0.2
0.4
0.6
0.8
1
1.2
0
10
20
30
40
0
2
4
6
8
10
12
14
16
Figure 1: Continued.Advances in Virology 5
0
5
10
00
5
10
15
20
25
30
5
10
15
20
25
30
35
0
2
4
6
8
10
12
R
e
a
l
-
t
i
m
e
R
T
-
P
C
R
t
r
a
n
s
c
r
i
p
t
a
b
u
n
d
a
n
c
e
(
f
o
l
d
c
h
a
n
g
e
)
15
20
(c)
R
e
a
l
-
t
i
m
e
R
T
-
P
C
R
t
r
a
n
s
c
r
i
p
t
a
b
u
n
d
a
n
c
e
(
f
o
l
d
c
h
a
n
g
e
)
R
e
a
l
-
t
i
m
e
R
T
-
P
C
R
t
r
a
n
s
c
r
i
p
t
a
b
u
n
d
a
n
c
e
(
f
o
l
d
c
h
a
n
g
e
)
06 1 2
BNIP3
16 24 0 61 2
Cytochrome p450
16 24
Time post-infection (hours) Time post-infection (hours)
Time post-infection (hours)
Time post-infection (hours)
Time post-infection (hours)
Time post-infection (hours)
0 0
10
20
30
40
50
0
5
10
20
25
0
0.2
0.4
0.6
0.8
1
1.2
1.4
0 6 12 16 24 0 6 12 16 24
0.2
0.4
0.6
0.8
1
1.2
1.4
GRP78
CXCL8 IL-1β
CCL3
SAGE
RT-PCR
24 mock
SAGE
RT-PCR
24 mock
0 6 12 16 24
SAGE
RT-PCR
24 mock
SAGE
RT-PCR
24 mock
0
0
61 2 1 6 2 4
SAGE
RT-PCR
24 mock
SAGE
RT-PCR
24 mock
0
0.5
1
1.5
2
0.2
0.4
0.6
0.8
1
1.2
1.4
0
10
20
30
40
50
60
70
0
5
10
15
25
20
30
Figure 1: Continued.6 Advances in Virology
Time post-infection (hours) Time post-infection (hours)
0 0
5
10
25
20
25
30
0
1
2
3
4
5
6
0 6 12 16 24 0 6 12 16 24
0.2
0.4
0.6
0.8
1
1.2
1.4
1.6
1.8
IL-6
R
e
a
l
-
t
i
m
e
R
T
-
P
C
R
t
r
a
n
s
c
r
i
p
t
a
b
u
n
d
a
n
c
e
(
f
o
l
d
c
h
a
n
g
e
)
(c)
Arginase
SAGE
RT-PCR
24 mock
SAGE
RT-PCR
24 mock
Figure 1: Real-time RT-PCR validation of SAGE results. Validation by real-time RT-PCR on RNA from the in vitro PRRSV-infected PAMs
samplesusedintheSAGEanalysisofselectedtranscriptsshowingdiﬀerentialtranscriptabundance.Real-timeRT-PCRtranscriptabundance
results (ﬁlled squares; left y-axis) expressed as the mean fold increase ± SEM in gene expression (n = 3) relative to mock-infected cells and
SAGE tag counts normalized to total tags per library (open diamonds; right y-axis) are shown for transcripts. The “24 mock” result shows
the real-time RT-PCR fold change in transcript abundance as a result of being in cell culture.
showed no signiﬁcant changes in the SAGE data. Interest-
ingly, IκBα showed a steady decline in transcript abundance
out to 24 hours PI while IκKα showed no signiﬁcant changes
over the course of the experiment. Activation of toll-like
receptor 4 (TLR4), a cell surface receptor that recognizes
bacterial cell membrane lipopolysaccharides, results in the
downstream activation of NF-κB. The transcript encoding
TLR4 showed a steady decline during the course of the
PRRSV infection (Table 2(c)).
An interesting ﬁnding was the sharp increase in arginase
transcript levels at 6 hours PI, with the RT-PCR and SAGE
data closely mimicking each other (Figure 1(c)). In addition,
atotaloffourdistincttags,presumablyrepresentingdiﬀerent
mRNA species, were found that were derived from arginase-
encoding transcripts; all showed increased transcript abun-
dance at 6 hours PI (Table 2(c)). The primer set used to
validate the arginase transcript levels ampliﬁed sequences
foundwithinthecodingsequencesofthetranscript,thus,the
real-time PCR results were from ampliﬁcation of sequences
from all four transcripts. The 6 hour PI time point examined
here represents only a “snap-shot” of the cells at that time, so
the full pattern of expression in not known.
3. Discussion
The derived catalog of expressed genes reported here repre-
sents a ﬁrst attempt to generate comprehensive analyses of
PRRSV-infected PAMs transcript abundance proﬁles at dif-
ferent time points after infection. The wealth of information
obtained allows detection of altered transcription of genes
involved in normal porcine alveolar macrophage physiology,
as well as genes whose transcript abundance is altered by
PRRSV infection.
The ability of an animal to respond to speciﬁc foreign
characteristics or molecular patterns of pathogens is an
important aspect of innate immunity. This is the ﬁrst,
generallyrapidstepintheresponsetoinvasionbyapathogen
and the beginning of a protective immune response. It is
important that this response begin quickly and in suﬃcient
fashion to stop the spread of the invader and terminate
the infection. In many cases, the pathogen possesses the
ability to inhibit or thwart the immediate innate immune
response, thus giving it an early advantage. Deciphering the
mechanisms of disruption of the innate immune response is
the focus of considerable research and is beginning to pro-
vide answers into the myriad of diﬀerent means pathogens
employ to achieve this. The focus here was to discern how
PRRSV inhibits the innate immune response in infected
PAMs.Thisstudyproducedtranscriptionalproﬁlesofnonin-
fected and PRRSV-infected PAMs that provided insight into
the suppression by the virus on host transcript abundance
levels necessary for a strong immune response. This work
has resulted in the characterization of macrophage transcript
abundance in normal cells as well as transcript abundance
changes that occurred with progressive PRRSV replication.
Virus-speciﬁc transcript abundance changes that were found
provided intriguing clues to possible mechanisms behind
immune suppression and the lack of a strong innate and
adaptive immune responses. Functional genomic analyses of
purepopulations ofPAMsfreshlyobtained fromhealthypigs
revealed that PRRS virus fails to elicit a signiﬁcant (>2-fold)
increase in the transcription of immune-related genes. The
characteroftheinnateimmuneresponsetoavirusisthought
to dictate the quality of the adaptive immune response that
ensues. Given the key roles that the cytokines produced by
cellsoftheinnateimmunesystem,playinthedevelopmentofAdvances in Virology 7
Table 2
(a) Changes in chemokine transcript abundance in PRRSV-infected PAMs
Transcript Function RT-PCR
Normalized SAGE tag counts (per million tags)
M o c k 6 1 21 62 4
CCL3 (MIP1α) Chemotaxis ↓ 191 21 3 0 21
CCL4 (MIP1β) Chemotaxis ↓ 419 68 25 19 16
CCL5 (RANTES) Chemotaxis nd 7 7 17 23 13
MIF Inhibits macrophage migration nd 8 1 25 35 32
CCL20 (MIP3α) Chemotaxis nd 196 78 14 19 11
C C L 2 ( M C P - 1 ) C h e m o t a x i s n d 11143 1
C C L 7 ( M C P - 3 ) C h e m o t a x i s n d 00412 2
CXCL2 (GROβ) Chemotaxis ↓ 1596 659 335 215 155
CXCL8
(AMCF-1/IL-8)∗ Chemotaxis 6hr ↑ 353
8
807
172
370
121
202
55
449
17
CXCL5 (AMCF-2) Chemotaxis 6hr ↑ 0 8 83 11 38 0
(b) Changes in cytokine transcript abundance in PRRSV-infected PAMs
Transcript Function RT-PCR
Normalized SAGE tag counts (per million tags)
Mock 6 12 16 24
IL-6 Acute phase response, T- and B-cell growth &
diﬀerentiation
↓ No tag in transcript
GM-CSF Dendritic cell growth & diﬀe r e n t i a t i o n n d 43104
TNF-α Local inﬂammation, endothelial activation nd 49 3 1 0 0
IL-1α T-cell activation, macrophage activation ↓ 152 31 23 16 40
Il-1β T-cell activation, macrophage activation ↓ 283 103 31 52 163
(c) Changes in immediate early-response transcript abundance in PRRSV-infected PAMs
Transcript Function RT-PCR
Normalized SAGE tag counts (per million tags)
Mock 6 12 16 24
AP-1 Transcription factor nd 1 0 0 0 0
C-jun Transcription factor for AP-1 nd 8 3 0 1 5
C-fos Transactivating regulator of gene expression nd 134 9 11 18 9
JunB Transcription factor for AP-1 nd 101 6 11 17 33
JunD Transcription factor for AP-1 nd 13 1 0 4 9
NFκB Transcription factor nd 2 1 3 0 0
IκBα NFκB inhibitor nd 205 72 42 11 26
IκKα Dissociates inhibitor from NFκB n d 47321
A20 Inhibits activation of transcription factors nd 11 12 6 1 4
TLR4 Activation of transcription factor NFκBn d 2 4 2 2 1 4 4 1 5
Arginase∗ Regulator of nitric oxide synthesis 6hr ↑
227
37
1
14
915
131
88
84
169
21
17
31
141
18
4
5
103
24
1
3
∗Alternative spliced transcripts.
adaptive immunity, clariﬁcation of the pathways responsible
for modulating their generation during the initial innate
immune response to PRRSV could have important impli-
cations in the development of eﬀective vaccines against this
major pathogen of swine. The results obtained in this project
helped us understand that the unique character of the innate
immuneresponsetoPRRSvirusislikelytobeinﬂuencingthe
qualityofadaptive(acquired)immuneresponsetothisvirus.
Thus, the knowledge derived from this study will contribute
to the elucidation of the molecular mechanisms controlling
the development of adaptive immunity in swine to PRRS
virus and will allow for the rational development of eﬀective
vaccines against this pathogen.
Previous work has demonstrated transcript abundance
diﬀerences in 13 genes between noninfected and PRRSV-
infected PAMs [33, 35, 45, 46]. More recently, Genini et al.8 Advances in Virology
Table 3: Real-time PCR primer sequences.
Transcript Sequence (1)
β2-microglobulin GCAGTCAGACCTGTCTTTCAGCAA
ATCTCTGTGATGCCGGTTAGTGGT
β-actin AGATGTGGATCAGCAAGCAGGAGT
AGCTAACAGTCCGCCTAGAAGCAT
A20 GATGCTGCCTTTGATGCTGGTCTT
AAAGCACACAGAGACACTGCAAGC
Arginase AAGAACGGAAGGACCAGCCTTGTA
TCGTGGTTGTCAGTGGAGTGTTGA
BNIP3 TTCGCGTCTCCTGAATCACCTGTA
AGTGCCTAACTCAAGGCTGCAGAT
CCL3 (MIP-1α) AAACAGCCACTCTCTGGGACTCAT
AAAGGTGTCTTCGGACCTCTTGGA
CCL4 (MIP-1β) AAGCTTCCTCGCAACTTCGTGACT
TCAGAGCAGCTCAGTTCAGTTCCA
CD163 TCTGTTGGCCTGTCTCATCGCATT
TCAGGCAAGAATTCATCTCCCGGT
CXCL2 GACCGTGCAAGGAATTCACCTCAA
CAGTTGGCACTGCTCTTGTTTAGC
CXCL5(AMCF2) AGCCACCCTGAAGAATGGAAAGGA
CTTCTGCTGAAGAACTGGGCGATT
CXCL8
(IL-8/AMCF1)
GCAGAACTTCGATGCCAGTGCATA
TCTGTACAACCTTCTGCACCCACT
Cytochrome P450
3A29
TACCTACGATGGTCTGGCGCAAAT
CGAACACGCCATGGATTTCCACAT
GRP78(2) TGGCATTCTTCGAGTGACTGCTGA
GTGTCAATGCGCTCCTTGAGCTTT
IL-1α TTCAAATCAGCCGCCCATCCAAAG
TGGTACATACGGCCTGTCAACACT
IL-1β GAAATGGGAGCATCCAGCTGCAAA
TTGCACGTTTCAAGGATGATGGGC
IL-6 ATGCTCTTCACCTCTCCGGACAAA
TTCTGCCAGTACCTCCTTGCTGTT
MIF TACTACGACATGAACGCGGCCAAT
GCGCCATCTCCACACCGTTTATTT
Mx1 TTCGCACATCCTCCTGTGGTTAGT
GCGTGCTTATCACAGCTTCTTGCT
PRRSV CAACGGCAAGCAGCAGAAGAGAAA
TGATCTTACCCAGCATCTGGCACA
RHIV TTTGGACTCTGTTCTCAGGCAGGT
AGACTTAAACCCGAGCCTCAGCAA
(1)First line of sequence is plus sense and second line is minus sense.
(2)Glucose responsive protein 78.
[47] proﬁled gene expression of PAMs infected in vitro with
the European Lelystad strain of PRRSV, with the biological
similaritiesbutdistinctserologicalpropertiesfromtheNorth
American VR-2332 isolate [48], over 12hp.i. by utilizing
an Aﬀymetrix 24K Porcine Chip array. In Genini’s study,
statistical analysis of variance (ANOVA) showed diﬀerential
expression of 1409 genes. After applying a cut-oﬀ threshold
based on a fold-change of 1.5 between infected and control
PAMs,148geneswerediﬀerentiallyexpressedcomparedwith
the controls [47]. In our study, greater than 590 signiﬁcant
(P<. 01) changes in transcript abundance levels were
identiﬁed.
Analysis of this transcriptomics data in the context of
gene ontology allows us to ascribe biological function to
thediﬀerentiatedtranscriptabundancedataset.TheP-values
and scores calculated in IPA act as starting points for further
investigation and act as rough guides for identiﬁcation of
signiﬁcant processes or pathways aﬀected in the experiment.
Note, however, that functions whose signiﬁcance values
exhibit little or no change from one time-point to another
may be changing.
However, an important aspect of this study was not in
what was altered, but rather what was not. Of particular
interest was the apparent lack of any overt innate immune
response in the PRRSV-infected PAMs. This was borne out
by the lack of increased transcription of chemokine and
cytokine genes that are commonly observed to increase in
infectionwithotherpathogens.TheseincludedCCL3,CCL4,
TNFα, type 1 interferons, and a number of proinﬂammatory
chemokines and cytokines.
In the initial stage of a PRRSV infection, the primary
target cells of the virus are PAMs. It is as yet unknown what
signals are necessary to call the immune system into action.
The most likely candidates are cytokines and particularly
those that initiate migration and activation of leukocytes.
Sprenger et al. [49] have shown that inﬂuenza A virus selec-
tivelyinducesmononuclearleukocyte-attractingchemokines
MIP-1, MCP-1, and RANTES and suppresses neutrophil-
attracting chemokines IL-8 and GRO-α. In this study, we
have shown that PPRSV does not activate an alveolar
macrophage proinﬂammatory response while suppressing
type 1 IFN production and apoptotic pathways. No activa-
tion of the PAMs was indicated by a decrease in IL-1α,I L - 6 ,
or IL-8. Knoetig et al. [50] has shown that IL-1 is released
from CSFV-infected macrophages. IL-8 is, for example, an
important chemo-attractant for immune cells, while IL-1
and IL-6 prime B- and T-cell responses against infected
cells. The chemokines CCL3 (MIP-1α), CCL4 (MIP-1β),
RANTES, MCP1, MCP3, and MIP3 are important chemo-
attractants and mediators of virus-induced inﬂammation
in vivo [51]. Cytokine mRNAs have a short half-life after
synthesis and the rapid reduction in mRNA levels a few
hours after addition of virus suggests rapid intracellular
cytokine mRNA degradation or suppressed transcription.
Virus replication and protein synthesis has been shown
to commence 10–15hPI [52] (although SAGE showed an
increase in viral RNAs at 6 hours PI), suggesting that any
increase in cytokine mRNA levels after 15hPI was due to
the presence of replicating virus. Similarly, we showed no
activation of NF-κB, indicating a lack of transcriptional
activation of these genes. The transcription factor NF-
κB is a central regulator of the transcript abundance of
these proinﬂammatory genes and many viruses manipulate
the NF-κB pathway, resulting in suppression of antiviral
responses or prevention of apoptosis [53].
The ﬁnding of a sharp spike in transcription of the
arginase gene at 6 hours PI may give a clue to the early events
following infection that inhibit an innate immune response.
Arginase competes with nitric oxide synthases (NOS) for the
substrate arginine for the production of nitric oxide (NO).
NO is an important early signal in many pathophysiologicAdvances in Virology 9
processes. Early inhibition of its production would have
an impact on downstream events. Increased transcript
abundance of arginase has been shown to modulate NO
production in macrophages and impact the downstream
immune response [54–56].
4. Conclusions
It is well established that many pathogens cause changes in
expression of speciﬁc genes that act to protect the host and
clear the infection. This type of response was not seen in
these PRRSV-infected PAMs. Of particular interest was the
minimal expression of genes that are involved in attracting
other immune cells to the area of the infection. Additionally,
therewasnoresponsebygenesthatcauseinﬂammation.This
is the ﬁrst comprehensive study to show the inhibition of an
immune response in PAMs by PRRSV. However, the results
have also given us tantalizing clues to the mechanism(s)
behind this inhibition. There are speciﬁc cellular proteins
that control the expression of the protective genes and future
studies of the genes, their transcript abundance, protein
level, and protein function will enhance our understanding
of the interaction of PRRSV with the porcine macrophage.
Possible outcomes may include identiﬁcation of virulence
mechanisms, development of diagnostic assays and rational
vaccine design to more eﬀectively limit viral replication and
spread.
5. Methods
5.1. Cells and Virus. Primary PAMs were isolated, cultured,
and infected, as previously described [57]. Brieﬂy, PAMs
were harvested from three clinically healthy, PRRS-negative
gilts 6–8 weeks of age. Animals were humanely euthanized,
following animal care and use protocols, and PAMs were
harvested under aseptic conditions. PAMs were tested by
PCR for porcine circovirus and Mycoplasma spp [58, 59]
and found to be free of both. Aliquots of PAMs were frozen
and stored in liquid nitrogen. Typical yields were 108–
109 PAMs with >95% viability. Immediately prior to use,
PAMs were thawed and viability of PAMs was determined
to be 85% to 90% by trypan blue dye exclusion. Viable
PAMs were cultured at 37◦C,5%CO2 inDulbecco’sModiﬁed
Eagles Media with 5% fetal bovine serum (FBS; Gibco-
Invitrogen, Carlsbad, CA) and 1% antibiotic/antimyotic
(Gibco-Invitrogen) for 2 hours. PRRSV strain VR-2332 [60]
stock was propagated in MARC-145 cells [61]a n ds t o r e d
frozen at −80◦C until use.
5.2. Infection and RNA Isolation. PAMs isolated from three
pigs were maintained separately. All three sets of PAMs
were treated identically. After establishing PAMs in culture,
cells were infected with PRRSV strain VR-2332. To achieve
a near synchronous infection, ﬂasks containing adherent
PAMs were infected at a multiplicity of infection (MOI) of
10 in chilled media and incubated at 4◦Cf o r1h o u rt oa l l o w
for virus binding, but not entry into the cell. Pre-warmed
m e d i aw a sa d d e da n dt h ec e l l sp l a c e da t3 7 ◦C, 5% CO2 until
collected for RNA isolation. Total cellular RNA was prepared
using the Qiagen RNeasy mini kit (Qiagen, Valencia, CA),
according to manufacturers instructions, from each PRRSV-
infected PAMs ﬂask at 0, 6, 12, 16 or 24 hours after infection.
Total cellular RNA from mock-infected PAMs was collected
at 0 and 24 hours.
5.3. SAGE Library Construction. SAGE libraries were con-
structed as described previously [62] using Nla III as the
anchoring enzyme. Each library was made from pooled
equimolar amounts of total RNA from each pig at each
time point. The SAGE libraries provided the population
means of the transcript abundance levels for each time point.
SAGE clones were ampliﬁed and sequenced using a high-
throughput sequencing pipeline with an ABI 3730 auto-
mated sequencer and ABI chemistry (Applied Biosystems
Inc., Foster City, CA). The SAGE libraries with tag counts
were submitted to GenBank GEO and have the accession
number GSE10346.
The database of tags derived from the raw sequence data
was analyzed to identity transcripts from which tags were
derived as well as their relative abundance. Tag sequences
were corrected for sequencing errors using R and sagenhaft
[63]. The libraries were normalized to total tags. Relative
abundance was calculated based upon the number of times
a tag was represented in a given SAGE library [64]. Tags were
mapped to transcripts and genes by exact regular expression
matching to sequences in GenBank, Harvard Gene Index,
and the Pig Expression Database (Japan) databases and
parsed into a modiﬁed Identitag database [65]. Multidimen-
sional statistical tests: Audic and Claverie pairwise test; the
Fisher’s exact test; Greller and Tobin test; the R test and
pairwise and general Chi-square tests [66]w e r ea p p l i e dt o
determine which changes in tag abundance were signiﬁcant.
The Fisher’s exact test was adequate for detecting diﬀerences
in gene expression when dealing with pairwise comparisons.
SAGE libraries were compared with each other to identify
common or diﬀerential patterns of transcript abundance.
Attention was given to those transcripts where transcript
abundance changes may aﬀect PAM function; particularly in
regard to innate immunity, antigen presentation, and intra-
and extracellular signaling.
5.4. Real-Time RT-PCR Validation. Validation of the results
and corroboration of the altered transcript abundance levels
were analyzed by real-time reverse transcription-PCR (RT-
PCR) on the individual sample of 100ng total RNA from
each pig at each time point. Real-time RT-PCR was done in
25μL reaction volumes using the SuperScript III Platinum
SYBR green One Step qRT-PCR kit (Invitrogen, Carlsbad,
CA) according to the supplier’s speciﬁcations. The primer
sets used for this analysis are shown in Table 1.A l lp r i m e r s
were used at 200nM. PCR cycling conditions were 95◦Cf o r
15 minutes followed by 40 cycles of 94◦C for 10 seconds,
60◦C for 30 seconds and 72◦C for 30 seconds using an
Opticon 2 ﬂuorescent thermocycler (BioRad, Inc., Hercules,
CA). Final analysis of ampliﬁcation products was done by
melt curve where the PCR reactions were heated from 50 to10 Advances in Virology
94◦Ca tar a t eo f0 . 5 ◦C /second. Equal ampliﬁcation kinetics
of the target and the reference genes (β2-microglobulin)
were conﬁrmed by serial dilutions as described [67]. Quan-
tiﬁcation of levels of mRNA were calculated using the
2−ΔΔCt method, which expresses mRNA in treated cells
relative to mock infected cells after normalizing to β2-
microglobulin (β2m) [68]. For real-time PCR and SAGE tag
count comparisons, β2-microglobulin (β2m) served as the
internal control where the number of SAGE tags for β2m
derived from this library and the ampliﬁcation curve from
real-time PCR were considered equal.
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